The routes those studies used and the routes people are buying dont overlap much: The FDA states it plainly: We found no studies that administered BPC-157 to humans via the proposed oral, SC, nasal, or transdermal ROA. Is BPC-157 FDA approved
Use only under veterinary supervision
Concentration = 10mg 2mL = 5mg/mL If a protocol step calls for 2mg, the injection volume is: 2mg 5mg/mL = 0.4mL On a standard U-100 insulin syringe (where 100 units = 1mL), 0.4mL converts to 40 units
Refrigeration at 28 C is appropriate once the working timeline extends past a month
TE, tracheo-esophageal
Most commonly, doctors will prescribe it for the following health conditions: Growth hormone deficiency According to a 2012 review published in BioDrugs , sermorelins primary therapeutic use has been to diagnose growth hormone deficiency .9 With a normally functioning pituitary gland, a patients growth hormone levels should reach a peak value within a specific time frame after sermorelin administration